100 related articles for article (PubMed ID: 18385039)
1. SRC-3 transcription-coupled activation, degradation, and the ubiquitin clock: is there enough coactivator to go around in cells?
Lonard DM; O'Malley BW
Sci Signal; 2008 Apr; 1(13):pe16. PubMed ID: 18385039
[TBL] [Abstract][Full Text] [Related]
2. SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock.
Wu RC; Feng Q; Lonard DM; O'Malley BW
Cell; 2007 Jun; 129(6):1125-40. PubMed ID: 17574025
[TBL] [Abstract][Full Text] [Related]
3. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells.
Mani A; Oh AS; Bowden ET; Lahusen T; Lorick KL; Weissman AM; Schlegel R; Wellstein A; Riegel AT
Cancer Res; 2006 Sep; 66(17):8680-6. PubMed ID: 16951183
[TBL] [Abstract][Full Text] [Related]
4. The SRC-3/AIB1 coactivator is degraded in a ubiquitin- and ATP-independent manner by the REGgamma proteasome.
Li X; Lonard DM; Jung SY; Malovannaya A; Feng Q; Qin J; Tsai SY; Tsai MJ; O'Malley BW
Cell; 2006 Jan; 124(2):381-92. PubMed ID: 16439211
[TBL] [Abstract][Full Text] [Related]
5. Review of the in vivo functions of the p160 steroid receptor coactivator family.
Xu J; Li Q
Mol Endocrinol; 2003 Sep; 17(9):1681-92. PubMed ID: 12805412
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine phosphorylation of the nuclear receptor coactivator AIB1/SRC-3 is enhanced by Abl kinase and is required for its activity in cancer cells.
Oh AS; Lahusen JT; Chien CD; Fereshteh MP; Zhang X; Dakshanamurthy S; Xu J; Kagan BL; Wellstein A; Riegel AT
Mol Cell Biol; 2008 Nov; 28(21):6580-93. PubMed ID: 18765637
[TBL] [Abstract][Full Text] [Related]
7. The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice.
Fereshteh MP; Tilli MT; Kim SE; Xu J; O'Malley BW; Wellstein A; Furth PA; Riegel AT
Cancer Res; 2008 May; 68(10):3697-706. PubMed ID: 18483252
[TBL] [Abstract][Full Text] [Related]
8. Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.
Myers E; Hill AD; Kelly G; McDermott EW; O'Higgins NJ; Buggy Y; Young LS
Clin Cancer Res; 2005 Mar; 11(6):2111-22. PubMed ID: 15788656
[TBL] [Abstract][Full Text] [Related]
9. SRC-3 is required for prostate cancer cell proliferation and survival.
Zhou HJ; Yan J; Luo W; Ayala G; Lin SH; Erdem H; Ittmann M; Tsai SY; Tsai MJ
Cancer Res; 2005 Sep; 65(17):7976-83. PubMed ID: 16140970
[TBL] [Abstract][Full Text] [Related]
10. Role of AIB1 for tamoxifen resistance in estrogen receptor-positive breast cancer cells.
Su Q; Hu S; Gao H; Ma R; Yang Q; Pan Z; Wang T; Li F
Oncology; 2008; 75(3-4):159-68. PubMed ID: 18827493
[TBL] [Abstract][Full Text] [Related]
11. Atypical protein kinase C regulates dual pathways for degradation of the oncogenic coactivator SRC-3/AIB1.
Yi P; Feng Q; Amazit L; Lonard DM; Tsai SY; Tsai MJ; O'Malley BW
Mol Cell; 2008 Feb; 29(4):465-76. PubMed ID: 18313384
[TBL] [Abstract][Full Text] [Related]
12. Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence.
Redmond AM; Bane FT; Stafford AT; McIlroy M; Dillon MF; Crotty TB; Hill AD; Young LS
Clin Cancer Res; 2009 Mar; 15(6):2098-106. PubMed ID: 19276281
[TBL] [Abstract][Full Text] [Related]
13. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.
Liao L; Kuang SQ; Yuan Y; Gonzalez SM; O'Malley BW; Xu J
J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):3-14. PubMed ID: 12650696
[TBL] [Abstract][Full Text] [Related]
14. Expression of steroid receptor coactivators in cultured cells from paired myometrial and fibroid tissues.
Hussein-Fikret S; Fuller PJ; Gargett CE
J Soc Gynecol Investig; 2005 Sep; 12(6):445-51. PubMed ID: 15979354
[TBL] [Abstract][Full Text] [Related]
15. Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chokkalingam AP; Gao YT; Wu G; Wang X; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Chiang T; Chen YL; Stanczyk FZ; Chang C
Cancer Epidemiol Biomarkers Prev; 2002 Apr; 11(4):337-41. PubMed ID: 11927493
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation by steroid receptor coactivator phosphorylation.
Wu RC; Smith CL; O'Malley BW
Endocr Rev; 2005 May; 26(3):393-9. PubMed ID: 15814849
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of steroid receptor coactivator-3 (SRC-3) gene overexpression by a positive regulatory loop of E2F1 and SRC-3.
Mussi P; Yu C; O'Malley BW; Xu J
Mol Endocrinol; 2006 Dec; 20(12):3105-19. PubMed ID: 16916939
[TBL] [Abstract][Full Text] [Related]
18. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
Bai Y; Giguére V
Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
[TBL] [Abstract][Full Text] [Related]
19. Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.
Xu J; Wu RC; O'Malley BW
Nat Rev Cancer; 2009 Sep; 9(9):615-30. PubMed ID: 19701241
[TBL] [Abstract][Full Text] [Related]
20. Steroid receptor coactivator-1 and its family members differentially regulate transactivation by the tumor suppressor protein p53.
Lee SK; Kim HJ; Kim JW; Lee JW
Mol Endocrinol; 1999 Nov; 13(11):1924-33. PubMed ID: 10551785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
